GTBP
GT Biopharma, Inc.Company with tickers: GTBP
CIK
109657
CUSIP
36254L308
Shares Outstanding
36,062,904
13F Activity (30d)
28 filings
26 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-22 | 2026-05-20 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-04-07 | 2026-04-03 | |
| 10-Q/A | 2026-03-06 | 2025-09-30 | |
| 10-Q/A | 2026-03-06 | 2025-06-30 | |
| 8-K | 2026-03-02 | 2026-03-01 | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 8-K | 2025-11-26 | 2025-11-20 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-09-26 | 2025-09-25 | |
| 8-K | 2025-09-23 | 2025-09-17 | |
| 8-K | 2025-08-29 | 2025-08-26 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-24 | — | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 8-K | 2025-05-27 | 2025-05-21 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-13 | 2025-05-07 | |
| 8-K | 2025-05-13 | 2025-05-12 | |
| 8-K | 2025-05-05 | 2025-04-29 | |
| 10-K/A | 2025-04-14 | 2024-12-31 | |
| 8-K | 2025-04-04 | 2025-03-31 | |
| 8-K | 2025-02-26 | 2025-02-25 | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-01-27 | — | |
| 8-K | 2024-11-27 | 2024-11-21 | |
| 8-K | 2024-11-21 | 2024-11-18 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-09-16 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-26 | 2024-06-25 | |
| 8-K | 2024-06-07 | 2024-06-03 | |
| 8-K | 2024-05-23 | 2024-05-21 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-04-30 | 2024-04-25 | |
| 10-K | 2024-03-26 | 2023-12-31 | |
| 8-K | 2024-02-01 | — | |
| 8-K | 2023-12-21 | 2023-12-18 | |
| 8-K | 2023-12-04 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-08-22 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-07-05 | 2023-06-28 | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 8-K | 2023-05-04 | 2023-05-01 | |
| 10-K | 2023-03-30 | 2022-12-31 | |
| 8-K | 2023-02-28 | 2023-02-22 | |
| 8-K | 2023-01-04 | 2022-12-30 |
Showing 1–50 of 101 filings